Cargando…

Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study

A biomarker for risk stratification and disease severity assessment in SARS-CoV-2 infections has not yet been established. Point of care testing (POCT) of butyrylcholinesterase (BChE) enables early detection of systemic inflammatory responses and correlates with disease severity in sepsis and burns....

Descripción completa

Detalles Bibliográficos
Autores principales:	Espeter, Florian, Künne, David, Garczarek, Lena, Kuhlmann, Henning, Skarabis, Annabell, Zivkovic, Aleksandar R., Brenner, Thorsten, Schmidt, Karsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498245/ https://www.ncbi.nlm.nih.gov/pubmed/36140551 http://dx.doi.org/10.3390/diagnostics12092150

Ejemplares similares

Bedside Hyperspectral Imaging and Organ Dysfunction Severity in Critically Ill COVID-19 Patients—A Prospective, Monocentric Observational Study
por: Kuhlmann, Henning, et al.
Publicado: (2023)

Reduced Serum Butyrylcholinesterase Activity Indicates Severe Systemic Inflammation in Critically Ill Patients
por: Zivkovic, Aleksandar R., et al.
Publicado: (2015)

Reduced butyrylcholinesterase activity is an early indicator of trauma-induced acute systemic inflammatory response
por: Zivkovic, Aleksandar R, et al.
Publicado: (2016)

Characteristics of Critically Ill Patients with COVID-19 Compared to Patients with Influenza—A Single Center Experience
por: Herbstreit, Frank, et al.
Publicado: (2021)

Effect of Dexamethasone on the Incidence and Outcome of COVID-19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients during First- and Second Pandemic Wave—A Single Center Experience
por: Dubler, Simon, et al.
Publicado: (2022)

Non-Neuronal Acetylcholinesterase Activity Shows Limited Utility for Early Detection of Sepsis
por: Zivkovic, Aleksandar R., et al.
Publicado: (2023)

Serum butyrylcholinesterase as a marker of COVID-19 mortality: Results of the monocentric prospective observational study
por: Markuskova, Lucia, et al.
Publicado: (2023)

Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
por: Pezzementi, Leo, et al.
Publicado: (2011)

Correction: Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes
por: Pezzementi, Leo, et al.
Publicado: (2011)

Molecular forms of butyrylcholinesterase and obesity
por: Boberg, Dellyana R., et al.
Publicado: (2010)

Caffeine Inhibits Acetylcholinesterase, But Not Butyrylcholinesterase
por: Pohanka, Miroslav, et al.
Publicado: (2013)

Electrochemical MIP Sensor for Butyrylcholinesterase
por: Ozcelikay, Goksu, et al.
Publicado: (2019)

Identification of Compounds for Butyrylcholinesterase Inhibition
por: Li, Shuaizhang, et al.
Publicado: (2021)

Data on microcirculatory parameters of GTS- 21 treated rats assessed by intravital microscopy
por: Schmidt, Karsten, et al.
Publicado: (2017)

Response to: Comment on “A Sustained Reduction in Serum Cholinesterase Enzyme Activity Predicts Patient Outcome following Sepsis”
por: Zivkovic, Aleksandar R., et al.
Publicado: (2019)

Development of an in-vivo active reversible butyrylcholinesterase inhibitor
por: Košak, Urban, et al.
Publicado: (2016)

Probing the Peripheral Site of Human Butyrylcholinesterase
por: Macdonald, Ian R., et al.
Publicado: (2012)

Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
por: Pohanka, Miroslav
Publicado: (2014)

Butyrylcholinesterase–Protein Interactions in Human Serum
por: Jasiecki, Jacek, et al.
Publicado: (2021)

Bedside-measurement of serum cholinesterase activity predicts patient morbidity and length of the intensive care unit stay following major traumatic injury
por: Zivkovic, Aleksandar R., et al.
Publicado: (2019)

Increased Enzymatic Activity of Acetylcholinesterase Indicates the Severity of the Sterile Inflammation and Predicts Patient Outcome following Traumatic Injury
por: Zivkovic, Aleksandar R., et al.
Publicado: (2023)

Sulphonamides incorporating 1,3,5-triazine structural motifs show antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibitory profile
por: Lolak, Nabih, et al.
Publicado: (2020)

Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes
por: Pajk, Stane, et al.
Publicado: (2020)

Cytidine-5-diphosphocholine reduces microvascular permeability during experimental endotoxemia
por: Schmidt, Karsten, et al.
Publicado: (2015)

Butyrylcholinesterase deficiency identified by preoperative patient interview
por: Lee, Serin, et al.
Publicado: (2013)

Effects of physical exercise on butyrylcholinesterase in obese adolescents
por: Silva, Isabela M.W., et al.
Publicado: (2012)

Dual inhibition of acetylcholinesterase and butyrylcholinesterase enzymes by allicin
por: Kumar, Suresh
Publicado: (2015)

Acetylcholinesterase and butyrylcholinesterase in cardiosurgical patients with postoperative delirium
por: John, Mira, et al.
Publicado: (2017)

Butyrylcholinesterase level in poisoned patients with phosphide compounds
por: Afzali, Saeed, et al.
Publicado: (2019)

Molecular interaction of inhibitors with human brain butyrylcholinesterase
por: Shakil, Shazi
Publicado: (2021)

Bacterial Expression of Human Butyrylcholinesterase as a Tool for Nerve Agent Bioscavengers Development
por: Brazzolotto, Xavier, et al.
Publicado: (2017)

A Sustained Reduction in Serum Cholinesterase Enzyme Activity Predicts Patient Outcome following Sepsis
por: Zivkovic, Aleksandar R., et al.
Publicado: (2018)

Obesity and variants of the GHRL (ghrelin) and BCHE (butyrylcholinesterase) genes
por: Dantas, Vitor G.L., et al.
Publicado: (2011)

Butyrylcholinesterase as a prognostic marker: a review of the literature
por: Santarpia, Lidia, et al.
Publicado: (2012)

Novel Human Butyrylcholinesterase Variants: Toward Organophosphonate Detoxication
por: Dwyer, Mary, et al.
Publicado: (2014)

Delipidation of Plasma Has Minimal Effects on Human Butyrylcholinesterase
por: Onder, Seda, et al.
Publicado: (2018)

Triterpene-Based Carboxamides Act as Good Inhibitors of Butyrylcholinesterase
por: Loesche, Anne, et al.
Publicado: (2019)

Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor
por: Zakošek Pipan, Maja, et al.
Publicado: (2021)

Discovery of pyrrole derivatives as acetylcholinesterase-sparing butyrylcholinesterase inhibitor
por: Sun, Shouyuan, et al.
Publicado: (2022)

Butyrylcholinesterase distribution in the mouse gastrointestinal tract: An immunohistochemical study
por: Severi, Ilenia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dnp8eh1osr2j7jnsb9efa2p8bv